Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn Lambert

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Vaccine|May 9, 2017
Accelerated and long term stability study of Pfs25-EPA conjugates adjuvanted with Alhydrogel®Daming Zhu, Yimin Wu, Holly McClellan, et al.
The American Journal of Tropical Medicine and Hygiene|January 25, 2017
<i>Grammomys surdaster</i>, the Natural Host for <i>Plasmodium berghei</i> Parasites, as a Model to Study Whole-Organism Vaccines Against MalariaSolomon Conteh, Charles Anderson, Lynn Lambert, et al.
Plos One|December 27, 2014
Neither the HIV protease inhibitor lopinavir-ritonavir nor the antimicrobial trimethoprim-sulfamethoxazole prevent malaria relapse in plasmodium cynomolgi-infected non-human primatesCharlotte V Hobbs, Saurabh Dixit, Scott R Penzak, et al.
Infection and Immunity|August 20, 2008
Identification and characterization of the Plasmodium yoelii PyP140/RON4 protein, an orthologue of Toxoplasma gondii RON4, whose cysteine-rich domain does not protect against lethal parasite challenge infectionDavid L Narum, Vu Nguyen, Yanling Zhang, et al.
Vaccine|April 22, 2008
Addition of CpG ODN to recombinant Pseudomonas aeruginosa ExoProtein A conjugates of AMA1 and Pfs25 greatly increases the number of respondersFeng Qian, Kelly M Rausch, Olga Muratova, et al.
Plos One|December 28, 2017
Protein-protein conjugate nanoparticles for malaria antigen delivery and enhanced immunogenicityPuthupparampil V Scaria, Beth Chen, Christopher G Rowe, et al.
Vaccine|April 20, 2005
Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malariaElissa M Malkin, Anna P Durbin, David J Diemert, et al.
Cell Host & Microbe|July 16, 2008
Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasionKaren Hayton, Deepak Gaur, Anna Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2001
A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparumAnthony W Stowers, Li-how Chen Lh, Yanling Zhang, et al.
Molecular and Biochemical Parasitology|December 17, 2008
Characterization of a protective Escherichia coli-expressed Plasmodium falciparum merozoite surface protein 3 indicates a non-linear, multi-domain structureChiawei W Tsai, Peter F Duggan, Albert J Jin, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Vaccine|May 9, 2017
Accelerated and long term stability study of Pfs25-EPA conjugates adjuvanted with Alhydrogel®Daming Zhu, Yimin Wu, Holly McClellan, et al.
The American Journal of Tropical Medicine and Hygiene|January 25, 2017
<i>Grammomys surdaster</i>, the Natural Host for <i>Plasmodium berghei</i> Parasites, as a Model to Study Whole-Organism Vaccines Against MalariaSolomon Conteh, Charles Anderson, Lynn Lambert, et al.
Plos One|December 27, 2014
Neither the HIV protease inhibitor lopinavir-ritonavir nor the antimicrobial trimethoprim-sulfamethoxazole prevent malaria relapse in plasmodium cynomolgi-infected non-human primatesCharlotte V Hobbs, Saurabh Dixit, Scott R Penzak, et al.
Infection and Immunity|August 20, 2008
Identification and characterization of the Plasmodium yoelii PyP140/RON4 protein, an orthologue of Toxoplasma gondii RON4, whose cysteine-rich domain does not protect against lethal parasite challenge infectionDavid L Narum, Vu Nguyen, Yanling Zhang, et al.
Vaccine|April 22, 2008
Addition of CpG ODN to recombinant Pseudomonas aeruginosa ExoProtein A conjugates of AMA1 and Pfs25 greatly increases the number of respondersFeng Qian, Kelly M Rausch, Olga Muratova, et al.
Plos One|December 28, 2017
Protein-protein conjugate nanoparticles for malaria antigen delivery and enhanced immunogenicityPuthupparampil V Scaria, Beth Chen, Christopher G Rowe, et al.
Vaccine|April 20, 2005
Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malariaElissa M Malkin, Anna P Durbin, David J Diemert, et al.
Cell Host & Microbe|July 16, 2008
Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasionKaren Hayton, Deepak Gaur, Anna Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2001
A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparumAnthony W Stowers, Li-how Chen Lh, Yanling Zhang, et al.
Molecular and Biochemical Parasitology|December 17, 2008
Characterization of a protective Escherichia coli-expressed Plasmodium falciparum merozoite surface protein 3 indicates a non-linear, multi-domain structureChiawei W Tsai, Peter F Duggan, Albert J Jin, et al.
Pageof 4